Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

HIKMA Lists on DIFX

25th Apr 2006 07:01

Hikma Pharmaceuticals Plc25 April 2006 Hikma to list Global Depositary Receipts on DIFX LONDON, 25 April 2006 - Hikma Pharmaceuticals PLC ("Hikma") (LSE: HIK), themultinational pharmaceuticals group, will tomorrow list Global DepositoryReceipts ("GDRs") on the Dubai International Financial Exchange ("DIFX"). The listing follows Hikma's initial public offering (the "IPO") of ordinaryshares on the London Stock Exchange in November 2005. This is a secondarylisting of existing shares and each GDR will represent two ordinary shares. Samih Darwazah, Chairman and Chief Executive of Hikma, said: "We are verypleased to announce the listing of our GDRs on the DIFX, in line with our statedintention at the time of our IPO. Through this listing, we hope to reinforce ourstrong profile in our Middle East and North Africa markets and to gain betteraccess to the diverse Middle East investor base." - ENDS - Enquiries: Hikma Pharmaceuticals PLC Susan Ringdal +44 20 7479 4893Investor Relations Director Brunswick Group Jon Coles / Wendel Verbeek / Justine McIlroy / Alex Tweed +44 20 7404 5959 About HikmaHikma Pharmaceuticals PLC is a multinational pharmaceutical group focused ondeveloping, manufacturing and marketing a broad range of both branded andnon-branded generic and in-licensed pharmaceutical products. Hikma's operationsare conducted through three businesses: Generic, Branded and InjectablePharmaceuticals. Hikma's operations are based principally in the United States,the Middle East and North Africa ("MENA") region and Europe. In 2005, the Grouphad revenue of $262 million and profit attributable to shareholders of $44million. At 31 December 2005, the Group had over 1,800 employees. For news andother information, please visit www.hikma.com. About DIFXThe DIFX is the region's first international financial exchange for equities,bonds, Islamic products, funds, index products and (subject to regulatoryapproval) derivatives. The target areas of the DIFX for seeking issuers includethe Middle East and North Africa, as well as South Africa, Turkey and the Indiansub-continent. The exchange launched in September 2005 and currently has 12Member banks. The regulator of the DIFX is the Dubai Financial ServicesAuthority. The DIFX is located in the Dubai International Financial Centre(DIFC) and its owner is the DIFC Authority. The trading hours of the DIFX arefrom 11:45am to 5pm (07:45am to 1pm GMT) from Monday to Friday. www.difx.ae This information is provided by RNS The company news service from the London Stock Exchange

Related Shares:

Hikma Pharmaceuticals
FTSE 100 Latest
Value9,187.34
Change-29.48